Literature DB >> 22664953

MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.

Wei Wei1, Zheng Hu, Hanjing Fu, Yi Tie, Haihong Zhang, Yongge Wu, Xiaofei Zheng.   

Abstract

MicroRNAs may function to promote or suppress tumor development, depending on the cellular context. The important role of microRNAs in regulating molecular pathways underlying tumorigenesis has been emphasized in hepatocellular carcinoma (HCC). MicroRNAs regulate gene expression via post-transcriptional mechanisms by inhibiting translation or by degrading mRNA. In this study, we show that microRNA-1 (miR-1) and microRNA-499 (miR-499) are capable of repressing the expression of the ets1 proto-oncogene, which plays a fundamental role in the extracellular matrix (ECM) degradation, a process required for tumor cell invasion and migration. We used luciferase reporter assays to demonstrate that miR-1 and miR-499 target the 3' untranslated region (UTR) of ets1. Overexpression of miR-1 and miR-499 in HepG2 cells led to downregulation of ets1 mRNA and protein as assessed by quantitative reverse transcription PCR and western blot analysis. Furthermore, overexpression of miR-1 and miR-499 inhibited the invasion and migration of HepG2 cells in matrigel invasion and transwell migration assays, respectively. These results suggest that miR-1 and miR-499 may play an important role in the pathogenesis of HCC by regulating ets1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664953     DOI: 10.3892/or.2012.1850

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.

Authors:  Yanyun Ma; Rui Wang; Jun Zhang; Wenshuai Li; Chunfang Gao; Jie Liu; Jiucun Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-22

2.  An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.

Authors:  Mo Wang; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Shuyuan Shen; Di Wang; Zhen Li; Heng Cai; Yunhui Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

3.  Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.

Authors:  Chao Hu; Shi-Qiang Shen; Zhong-Hui Cui; Zu-Bing Chen; Wei Li
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.

Authors:  Pablo Letelier; Patricia García; Pamela Leal; Héctor Álvarez; Carmen Ili; Jaime López; Jonathan Castillo; Priscilla Brebi; Juan Carlos Roa
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

6.  miR‑200b upregulation promotes migration of BEAS‑2B cells following long‑term exposure to cigarette smoke by targeting ETS1.

Authors:  Jin Wang; Ruixin Yao; Qiulin Luo; Lirong Tan; Beibei Jia; Nan Ouyang; Yezhou Li; Jian Tong; Jianxiang Li
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

7.  MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.

Authors:  Chao Han; Yubing Zhou; Qi An; Feng Li; Duolu Li; Xiaojian Zhang; Zujing Yu; Lili Zheng; Zhenfeng Duan; Quancheng Kan
Journal:  Tumour Biol       Date:  2015-04-01

Review 8.  MicroRNAs: understanding their role in gene expression and cancer.

Authors:  Ariany Lima Jorge; Erik Ribeiro Pereira; Christian Sousa de Oliveira; Eduardo Dos Santos Ferreira; Edmara Toledo Ninzoli Menon; Susana Nogueira Diniz; Julia Alejandra Pezuk
Journal:  Einstein (Sao Paulo)       Date:  2021-07-16

9.  Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice.

Authors:  Jessica L Fleming; Dustin L Gable; Somayeh Samadzadeh-Tarighat; Luke Cheng; Lianbo Yu; Jessica L Gillespie; Amanda Ewart Toland
Journal:  PeerJ       Date:  2013-04-16       Impact factor: 2.984

Review 10.  Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  Diagnostics (Basel)       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.